Single site-specific integration targeting coupled with embryonic stem cell differentiation provides a high-throughput alternative to in vivo enhancer analyses. (2013)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1242/bio.20136296
PubMed Identifier: 24244860
Publication URI: http://europepmc.org/abstract/MED/24244860
Type: Journal Article/Review
Volume: 2
Parent Publication: Biology open
Issue: 11
ISSN: 2046-6390